AlphaQuest’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,454
Closed -$1.85M 304
2025
Q4
$1.85M Buy
19,454
+10,710
+122% +$1.05M 0.1% 220
2025
Q3
$854K Buy
8,744
+1,442
+20% +$149K 0.06% 498
2025
Q2
$784K Sell
7,302
-14,238
-66% -$1.44M 0.08% 397
2025
Q1
$2.17M Sell
21,540
-6,418
-23% -$646K 0.24% 81
2024
Q4
$2.5M Buy
27,958
+10,172
+57% +$895K 0.33% 29
2024
Q3
$1.49M Buy
17,786
+1,668
+10% +$131K 0.13% 229
2024
Q2
$1.24M Sell
16,118
-2,443
-13% -$179K 0.17% 188
2024
Q1
$1.27M Buy
18,561
+18,560
+1,856,000% +$1.19M 0.22% 142
2023
Q4
$58 Buy
+1
New +$53 ﹤0.01% 1050

Other funds holding BSX

AlphaQuest's BSX Position: Q1 2026 in Review

AlphaQuest sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 19,454 shares — an estimated $1.85M sold.

AlphaQuest first reported a position in BSX in Q4 2023 and held it in 9 quarters. The position peaked at $2.5M in Q4 2024. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • AlphaQuest reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 19,454 Boston Scientific shares in Q1 2026, an estimated $1.85M.
  • AlphaQuest first reported a position in Boston Scientific in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Boston Scientific position peaked at $2.5M in Q4 2024.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.